Medicare Enrolled

Dr. Veronica Eberhart, AGACNP

Gerontology Nurse Practitioner · Braselton, GA
Low-engagement
1404 RIVER PL STE 501, Braselton, GA 30517
7705342020
In practice since 2015 (11 years)
NPI: 1073902094 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eberhart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eberhart? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eberhart

Dr. Veronica Eberhart is a gerontology nurse practitioner in Braselton, GA, with 11 years of NPI registration.

Between the years covered by Open Payments, Dr. Eberhart received a total of $4,555 from 24 pharmaceutical and/or device companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gerontology nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eberhart is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice $4,555 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,555
Total received (2021-2024)
Avg $1,139/year across 4 years
Top 6% in GA for gerontology nurse practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
194
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,555 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,692
2023
$1,366
2022
$783
2021
$714

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$291
Janssen Pharmaceuticals, Inc
$252
Merck Sharp & Dohme LLC
$250
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$188
ABIOMED
$132
PFIZER INC.
$109
AstraZeneca Pharmaceuticals LP
$82
Novartis Pharmaceuticals Corporation
$71
Amgen Inc.
$69
Lexicon Pharmaceuticals, Inc.
$68
E.R. Squibb & Sons, L.L.C.
$33
Bayer Healthcare Pharmaceuticals Inc.
$29
Alnylam Pharmaceuticals Inc.
$24
Impulse Dynamics (USA) Inc.
$20
SCPHARMACEUTICALS INC.
$17
Philips North America LLC
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Esperion Therapeutics, Inc.
$15
Actelion Pharmaceuticals US, Inc.
$11
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Pharmaceuticals, Inc
$1,313
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$619
Amgen Inc.
$506
Merck Sharp & Dohme LLC
$412
PFIZER INC.
$337
Boston Scientific Corporation
$312
AstraZeneca Pharmaceuticals LP
$250
Novartis Pharmaceuticals Corporation
$184
ABIOMED
$132
Lexicon Pharmaceuticals, Inc.
$68
Actelion Pharmaceuticals US, Inc.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Impulse Dynamics (USA) Inc.
$37
E.R. Squibb & Sons, L.L.C.
$33
Abbott Laboratories
$31
SCPHARMACEUTICALS INC.
$30
Esperion Therapeutics, Inc.
$30
Amarin Pharma Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$29
Edwards Lifesciences Corporation
$25
Alnylam Pharmaceuticals Inc.
$24
Novo Nordisk Inc
$17
Philips North America LLC
$17
BOSTON SCIENTIFIC CORPORATION
$16
Top 3 companies account for 53.5% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AMVUTTRA · BRILINTA · CAMZYOS · CARDIOMEMS · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · Impella · JARDIANCE · Kerendia · LEQVIO · LifeVest · NEXLETOL · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · Repatha · VERQUVO · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for gerontology nurse practitioner in GA.

Looking for a gerontology nurse practitioner in Braselton?
Compare gerontology nurse practitioners in the Braselton area by procedure volume, costs, and industry payment transparency.
Browse gerontology nurse practitioners nearby

Geographic Context

Gerontology nurse practitioners within 10 mi
55
Per 100K population
68.2
County median income
$85,012
Nearest hospital
NGMC BARROW, LLC
10.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Eberhart is a gerontology nurse practitioner, with low-engagement industry engagement in the top 6% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Eberhart receive payments from pharmaceutical companies?
Yes. Dr. Eberhart received a total of $4,555 from 24 companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Eberhart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →